vs
Side-by-side financial comparison of Guardian Pharmacy Services, Inc. (GRDN) and ROGERS CORP (ROG). Click either name above to swap in a different company.
Guardian Pharmacy Services, Inc. is the larger business by last-quarter revenue ($397.6M vs $200.5M, roughly 2.0× ROGERS CORP). Guardian Pharmacy Services, Inc. runs the higher net margin — 5.3% vs 2.2%, a 3.0% gap on every dollar of revenue.
CVS Pharmacy Inc. is an American retail corporation. A subsidiary of CVS Health, it is headquartered in Woonsocket, Rhode Island. Originally named the Consumer Value Stores, it was founded in Lowell, Massachusetts, in 1963.
Rogers Corporation is a specialty engineered materials company headquartered in Chandler, Arizona.
GRDN vs ROG — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $397.6M | $200.5M |
| Net Profit | $20.9M | $4.5M |
| Gross Margin | 21.5% | 32.2% |
| Operating Margin | 7.7% | — |
| Net Margin | 5.3% | 2.2% |
| Revenue YoY | — | 5.2% |
| Net Profit YoY | — | 421.4% |
| EPS (diluted) | — | $0.25 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $200.5M | ||
| Q4 25 | $397.6M | $201.5M | ||
| Q3 25 | $377.4M | $216.0M | ||
| Q2 25 | $344.3M | $202.8M | ||
| Q1 25 | $329.3M | $190.5M | ||
| Q4 24 | — | $192.2M | ||
| Q3 24 | $314.4M | $210.3M | ||
| Q2 24 | — | $214.2M |
| Q1 26 | — | $4.5M | ||
| Q4 25 | $20.9M | $4.6M | ||
| Q3 25 | $9.8M | $8.6M | ||
| Q2 25 | $9.0M | $-73.6M | ||
| Q1 25 | $9.4M | $-1.4M | ||
| Q4 24 | — | $-500.0K | ||
| Q3 24 | $-122.0M | $10.7M | ||
| Q2 24 | — | $8.1M |
| Q1 26 | — | 32.2% | ||
| Q4 25 | 21.5% | 31.5% | ||
| Q3 25 | 19.8% | 33.5% | ||
| Q2 25 | 19.8% | 31.6% | ||
| Q1 25 | 19.5% | 29.9% | ||
| Q4 24 | — | 32.1% | ||
| Q3 24 | 19.4% | 35.2% | ||
| Q2 24 | — | 34.1% |
| Q1 26 | — | — | ||
| Q4 25 | 7.7% | 3.5% | ||
| Q3 25 | 4.3% | 7.3% | ||
| Q2 25 | 3.7% | -33.3% | ||
| Q1 25 | 3.9% | -0.2% | ||
| Q4 24 | — | -6.6% | ||
| Q3 24 | -33.3% | 6.9% | ||
| Q2 24 | — | 5.3% |
| Q1 26 | — | 2.2% | ||
| Q4 25 | 5.3% | 2.3% | ||
| Q3 25 | 2.6% | 4.0% | ||
| Q2 25 | 2.6% | -36.3% | ||
| Q1 25 | 2.9% | -0.7% | ||
| Q4 24 | — | -0.3% | ||
| Q3 24 | -38.8% | 5.1% | ||
| Q2 24 | — | 3.8% |
| Q1 26 | — | $0.25 | ||
| Q4 25 | — | $0.20 | ||
| Q3 25 | — | $0.48 | ||
| Q2 25 | — | $-4.00 | ||
| Q1 25 | — | $-0.08 | ||
| Q4 24 | — | $-0.04 | ||
| Q3 24 | — | $0.58 | ||
| Q2 24 | — | $0.44 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $65.6M | $195.8M |
| Total DebtLower is stronger | $0 | — |
| Stockholders' EquityBook value | $217.9M | $1.2B |
| Total Assets | $412.7M | $1.4B |
| Debt / EquityLower = less leverage | 0.00× | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $195.8M | ||
| Q4 25 | $65.6M | $197.0M | ||
| Q3 25 | $36.5M | $167.8M | ||
| Q2 25 | $18.8M | $157.2M | ||
| Q1 25 | $14.0M | $175.6M | ||
| Q4 24 | — | $159.8M | ||
| Q3 24 | $37.2M | $146.4M | ||
| Q2 24 | — | $119.9M |
| Q1 26 | — | — | ||
| Q4 25 | $0 | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $34.3M | — | ||
| Q2 24 | — | — |
| Q1 26 | — | $1.2B | ||
| Q4 25 | $217.9M | $1.2B | ||
| Q3 25 | $195.5M | $1.2B | ||
| Q2 25 | $179.7M | $1.2B | ||
| Q1 25 | $163.2M | $1.3B | ||
| Q4 24 | — | $1.3B | ||
| Q3 24 | $133.9M | $1.3B | ||
| Q2 24 | — | $1.3B |
| Q1 26 | — | $1.4B | ||
| Q4 25 | $412.7M | $1.4B | ||
| Q3 25 | $390.0M | $1.4B | ||
| Q2 25 | $356.3M | $1.5B | ||
| Q1 25 | $334.0M | $1.5B | ||
| Q4 24 | — | $1.5B | ||
| Q3 24 | $348.0M | $1.5B | ||
| Q2 24 | — | $1.5B |
| Q1 26 | — | — | ||
| Q4 25 | 0.00× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.26× | — | ||
| Q2 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $34.6M | $5.8M |
| Free Cash FlowOCF − Capex | — | $1.1M |
| FCF MarginFCF / Revenue | — | 0.5% |
| Capex IntensityCapex / Revenue | — | 2.3% |
| Cash ConversionOCF / Net Profit | 1.65× | 1.29× |
| TTM Free Cash FlowTrailing 4 quarters | — | $70.1M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $5.8M | ||
| Q4 25 | $34.6M | $46.9M | ||
| Q3 25 | $28.2M | $28.9M | ||
| Q2 25 | $19.9M | $13.7M | ||
| Q1 25 | $17.6M | $11.7M | ||
| Q4 24 | — | $33.7M | ||
| Q3 24 | — | $42.4M | ||
| Q2 24 | — | $22.9M |
| Q1 26 | — | $1.1M | ||
| Q4 25 | — | $42.2M | ||
| Q3 25 | $24.2M | $21.2M | ||
| Q2 25 | — | $5.6M | ||
| Q1 25 | — | $2.1M | ||
| Q4 24 | — | $18.3M | ||
| Q3 24 | — | $25.2M | ||
| Q2 24 | — | $8.8M |
| Q1 26 | — | 0.5% | ||
| Q4 25 | — | 20.9% | ||
| Q3 25 | 6.4% | 9.8% | ||
| Q2 25 | — | 2.8% | ||
| Q1 25 | — | 1.1% | ||
| Q4 24 | — | 9.5% | ||
| Q3 24 | — | 12.0% | ||
| Q2 24 | — | 4.1% |
| Q1 26 | — | 2.3% | ||
| Q4 25 | — | 2.3% | ||
| Q3 25 | 1.1% | 3.6% | ||
| Q2 25 | — | 4.0% | ||
| Q1 25 | — | 5.0% | ||
| Q4 24 | — | 8.0% | ||
| Q3 24 | — | 8.2% | ||
| Q2 24 | — | 6.6% |
| Q1 26 | — | 1.29× | ||
| Q4 25 | 1.65× | 10.20× | ||
| Q3 25 | 2.87× | 3.36× | ||
| Q2 25 | 2.21× | — | ||
| Q1 25 | 1.86× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 3.96× | ||
| Q2 24 | — | 2.83× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
